01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

Open Orphan – Result of General Meeting June 11, 2020 – Posted in: Open Orphan (ORPH)

Thursday 11th June, 2020 Open Orphan plc (“Open Orphan”, or the “Company”) Result of General Meeting Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, is pleased to announce that at the Company’s General Meeting held earlier today in relation to the Fundraising, all of the Resolutions put to the meeting were duly passed. The Conditional…

Continue reading

Open Orphan #ORPH – Major New Contract Win for Venn Life Sciences – Posted in: Open Orphan (ORPH)

Open Orphan plc (ORPH) a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, is pleased to announce that it has signed a major contract with a leading vaccine developer and one of the top pharmaceutical companies in the world. The contract with Venn Life Sciences, which is part of Open Orphan, builds on earlier successful contracts between the companies…

Continue reading

Coronavirus vaccine: wanted — human guinea pigs to be infected with Covid-19 June 8, 2020 – Posted in: Open Orphan (ORPH)

Sabah Meddings Sunday June 07 2020, 12.01am, The Sunday Times Vaccine developers may have to resort to a method known as a ‘human challenge study’ KOEN VAN WEEL Scientists are applying for permission to infect healthy volunteers with Covid-19 amid fears the number of cases in the UK has fallen so steeply that it will be difficult to test potential vaccines. The health research company Hvivo, which runs a quarantine laboratory in east London, has…

Continue reading

Open Orphan plc – Launch of Covid-19 Antibody Testing June 4, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan plc      (“Open Orphan” or the “Company”) Launch of Covid-19 Antibody Testing Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, announces the launch of hVIVO COVID Clear Test, the Company’s antibody testing service, following the successful completion of installation, testing and training. The antibody tests, which utilise the Quotient MosaiQ™ system and…

Continue reading

Cathal Friel, CEO of Open Orphan (ORPH) discusses the appointment of David Kelly as an Independent Non-Executive Director on the Vox Podcast August 1, 2019 – Posted in: Open Orphan (ORPH)

Cathal Friel, Chief Executive Officer of Open Orphan (ORPH) talks about the appointment to the board of David Kelly as an Independent Non-Executive Director. Open Orphan plc is a European-focussed, rare and orphan drug consulting services platform. The Company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to…

Continue reading

Open Orphan (ORPH) sells its remaining shareholding in Integumen plc July 12, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, announces that it has now sold its remaining shareholding in Integumen plc following its disposal of 30,071,428 ordinary shares. The total proceeds of the sale are £566,846. This completes the process begun with the divestment of Innovenn UK limited to Integumen plc in November 2016. The disposal allows the Company to focus all its resources on its core strategy of creating a focused orphan drug platform…

Continue reading